<unk> , sold under the brand name Lamzede, is a medication for the treatment of alpha-mannosidosis.<unk>  is a recombinant form of human alpha-mannosidase.<unk>  was approved for medical use in the European Union in March 2018.
Velmanase alfa
Asfotase alfa
Angiozyme
Sebelipase alfa
Celadrin 
Efgartigimod alfa
Sulfatide
Vonicog alfa